Expert Opinion on Drug Safety, Volume 22, Issue 7 (2023)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Drug Safety, Volume 22, Issue 7 (2023)

See all volumes and issues
Vol 23, 2024 Volume 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Drug Safety Evaluation

Review Article
Efficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation
Alessia Villani, Massimiliano Scalvenzi, Giuseppe Micali, Francesco Lacarrubba, Lucia Genco, Angelo Ruggiero, Luigi Fornaro, Gianluca Guerrasio & Luca Potestio
Pages: 525-531
Published online: 20 Jun 2023
AbstractforEfficacy and safety of sonidegib for the management of basal cell carcinoma: a drug safety evaluation | Full Text | References | PDF (244.9 KB) | EPUB
  • 106 Views
  • 1 CrossRef citations
  • 0Altmetric
Review Article
The safety of ceftolozane/tazobactam for the treatment of complicated urinary tract infections
Matteo Bassetti, Antonio Vena & Daniele Roberto Giacobbe
Pages: 533-540
Published online: 03 Jul 2023
AbstractforThe safety of ceftolozane/tazobactam for the treatment of complicated urinary tract infections | Full Text | References | PDF (272.4 KB) | EPUB
  • 222 Views
  • 0 CrossRef citations
  • 0Altmetric

Perspective

Will the future of pharmacovigilance be more automated?
Francesco Salvo, Joelle Micallef, Amir Lahouegue, Laurent Chouchana, Louis Létinier, Jean-Luc Faillie & Antoine Pariente
Pages: 541-548
Published online: 12 Jul 2023
AbstractforWill the future of pharmacovigilance be more automated? | Full Text | References | PDF (335.5 KB) | EPUB
  • 255 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
A safety review of prophylaxis drugs for adolescent patients with hereditary angioedema
Henriette Farkas & Zsuzsanna Balla
Pages: 549-561
Published online: 21 Jun 2023
AbstractforA safety review of prophylaxis drugs for adolescent patients with hereditary angioedema | Full Text | References | PDF (1.3 MB) | EPUB
  • 129 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Safety review of current pharmacotherapies for levodopa-treated patients with Parkinson’s disease
Angela M Richmond, Kelly E Lyons & Rajesh Pahwa
Pages: 563-579
Published online: 04 Jul 2023
AbstractforSafety review of current pharmacotherapies for levodopa-treated patients with Parkinson’s disease | Full Text | References | PDF (912.3 KB) | EPUB
  • 295 Views
  • 0 CrossRef citations
  • 0Altmetric

Meta-analysis

Risks of cardiovascular toxicities associated with ALK tyrosine kinase inhibitors in patients with non-small-cell lung cancer: a meta-analysis of randomized control trials
Jin Zhao, Zhuo Ma, Hao Li, Dan Sun, Yi Hu, Chen Zhang & Yuhui Zhang
Pages: 581-588
Published online: 26 Feb 2023
AbstractforRisks of cardiovascular toxicities associated with ALK tyrosine kinase inhibitors in patients with non-small-cell lung cancer: a meta-analysis of randomized control trials | Full Text | References | PDF (2.3 MB) | EPUB | Supplemental
  • 192 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Performance of subgrouped proportional reporting ratios in the US Food and Drug Administration (FDA) adverse event reporting system
Daniel G. Dauner, Rui Zhang, Terrence J. Adam, Eleazar Leal, Viviene Heitlage & Joel F. Farley
Pages: 589-597
Published online: 07 Mar 2023
AbstractforPerformance of subgrouped proportional reporting ratios in the US Food and Drug Administration (FDA) adverse event reporting system | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 126 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Thromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review
Siyuan Gao, Yu Li, Zhichao He, Jianhong Zhu, Dan Liang, Shan Yang, Jiayao Mo, Kakei Lam, Xiaoxia Yu, Ming Huang & Junyan Wu
Pages: 599-609
Published online: 23 Feb 2023
AbstractforThromboembolism profiles associated with cyclin-dependent kinase 4/6 inhibitors: a real-world pharmacovigilance study and a systematic review | Full Text | References | PDF (4.7 MB) | EPUB | Supplemental
  • 618 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
The impact of pharmacist intervention on the intravenous-to-oral switch therapy of proton pump inhibitors in cardiovascular surgery
Jianan Bao, Ling Zhou, Mengying Xu & Jingjing Ma
Pages: 611-619
Published online: 02 Feb 2023
AbstractforThe impact of pharmacist intervention on the intravenous-to-oral switch therapy of proton pump inhibitors in cardiovascular surgery | Full Text | References | PDF (1.2 MB) | EPUB
  • 94 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Identification of adverse drug reactions that may be related to pharmacogenetics in a public hospital in the South of Brazil
Amanda C. Camargo, Ursula Matte & Mariana R. Botton
Pages: 621-627
Published online: 26 Feb 2023
AbstractforIdentification of adverse drug reactions that may be related to pharmacogenetics in a public hospital in the South of Brazil | Full Text | References | PDF (454.7 KB) | EPUB
  • 164 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Application of tree-based machine learning classification methods to detect signals of fluoroquinolones using the Korea Adverse Event Reporting System (KAERS) database
Min-Gyo Jang, SangHun Cha, Seunghwak Kim, Sojung Lee, Kyeong Eun Lee & Kwang-Hee Shin
Pages: 629-636
Published online: 23 Feb 2023
AbstractforApplication of tree-based machine learning classification methods to detect signals of fluoroquinolones using the Korea Adverse Event Reporting System (KAERS) database | Full Text | References | PDF (1.6 MB) | EPUB | Supplemental
  • 170 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles